The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
CheManager, 20 October 2020
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Silicon Republic, October 2, 2020
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Commitment to partnership and joint innovation for cell and gene therapies